Collegium Pharmaceutical
COLL
Constellation Brands
STZ
Ermenegildo Zegna NV
ZGN
DexCom
DXCM
Workday
WDAY
(Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 10.28%711.27M | 6.73%2.71B | 7.76%746.29M | 3.07%717.85M | 2.89%601.88M | 13.95%644.96M | 26.32%2.54B | 7.24%692.52M | 26.50%696.49M | 49.28%584.99M |
Operating revenue | 9.15%854.67M | 6.73%2.71B | 19.04%331.16M | 2.10%868.05M | 2.89%601.88M | 38.35%783.06M | 26.32%2.54B | -56.95%278.19M | 54.42%850.19M | 49.28%584.99M |
Excise taxes | 3.84%143.4M | 0.87%569.5K | -0.19%-415.13M | -2.28%150.2M | ---- | --138.1M | 20.87%564.6K | ---414.34M | --153.7M | ---- |
Cost of revenue | 10.42%664.38M | 6.73%2.53B | 8.20%697.51M | 3.12%669.89M | 2.89%559.57M | 13.30%601.66M | 25.81%2.37B | 6.50%644.65M | 25.68%649.62M | 48.92%543.86M |
Gross profit | 8.30%46.89M | 6.74%182.35M | 1.89%48.78M | 2.33%47.96M | 2.86%42.31M | 23.82%43.3M | 33.77%170.84M | 18.41%47.88M | 39.16%46.87M | 54.19%41.13M |
Operating expense | 9.49%43.22M | 13.46%164.37M | 7.19%43.59M | 8.68%42.34M | 8.83%38.97M | 34.05%39.48M | 37.82%144.88M | 25.39%40.67M | 45.49%38.95M | 57.50%35.8M |
Selling and administrative expenses | 8.93%40.59M | 12.80%154.88M | 7.74%41.02M | 8.33%39.92M | 7.89%36.68M | 31.29%37.26M | 35.31%137.3M | 21.62%38.07M | 42.49%36.85M | 55.13%34M |
Depreciation amortization depletion | 18.77%2.64M | 25.32%9.5M | -0.89%2.57M | 14.82%2.42M | 26.64%2.29M | 107.23%2.22M | 107.93%7.58M | 129.84%2.59M | 130.51%2.1M | 120.94%1.81M |
-Depreciation and amortization | 18.77%2.64M | 25.32%9.5M | -0.89%2.57M | 14.82%2.42M | 26.64%2.29M | 107.23%2.22M | 107.93%7.58M | 129.84%2.59M | 130.51%2.1M | 120.94%1.81M |
Operating profit | -4.00%3.67M | -30.76%17.98M | -27.98%5.19M | -28.93%5.62M | -37.24%3.34M | -30.74%3.82M | 14.89%25.97M | -9.88%7.21M | 14.62%7.91M | 35.11%5.33M |
Net non-operating interest income expense | -23.15%-2.85M | -21.79%-10.41M | -28.21%-2.95M | -21.71%-2.9M | -3.60%-2.25M | -36.44%-2.31M | -280.09%-8.55M | -124.10%-2.3M | -263.80%-2.39M | -785.82%-2.17M |
Non-operating interest expense | 23.15%2.85M | 21.79%10.41M | 28.21%2.95M | 21.71%2.9M | 3.60%2.25M | 36.44%2.31M | 280.09%8.55M | 124.10%2.3M | 263.80%2.39M | 785.82%2.17M |
Other net income (expense) | -122.92%-83.28K | 7.88%-104.8K | 48.45%-210.39K | -234.83%-314.42K | 219.69%56.62K | 235.09%363.4K | -110.12%-113.76K | 40.79%-408.1K | -86.38%233.19K | -177.60%-47.31K |
Other non- operating income (expenses) | -122.92%-83.28K | 7.88%-104.8K | 48.45%-210.39K | -234.83%-314.42K | 219.69%56.62K | 235.09%363.4K | -110.12%-113.76K | 40.79%-408.1K | -86.38%233.19K | -177.60%-47.31K |
Income before tax | -60.51%740.42K | -56.87%7.46M | -54.87%2.03M | -58.25%2.4M | -62.95%1.15M | -52.34%1.87M | -19.43%17.3M | -28.38%4.5M | -27.64%5.76M | -17.25%3.11M |
Income tax | -51.24%392K | -45.22%3.13M | -48.50%794.13K | -49.56%914.88K | -41.36%613K | -38.38%804K | -11.85%5.71M | -7.24%1.54M | -18.33%1.81M | -22.28%1.05M |
Net income | -67.47%348.42K | -62.60%4.34M | -58.19%1.24M | -62.24%1.49M | -73.88%539.54K | -59.26%1.07M | -30.44%11.6M | -35.99%2.96M | -34.75%3.94M | -31.29%2.07M |
Net income continuous Operations | -67.47%348.42K | -62.60%4.34M | -58.19%1.24M | -62.24%1.49M | -73.88%539.54K | -59.26%1.07M | -30.44%11.6M | -35.99%2.96M | -34.75%3.94M | -31.29%2.07M |
Minority interest income | ||||||||||
Net income attributable to the parent company | -67.47%348.42K | -62.60%4.34M | -58.19%1.24M | -62.24%1.49M | -73.88%539.54K | -59.26%1.07M | -30.44%11.6M | -35.99%2.96M | -34.75%3.94M | -31.29%2.07M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -67.47%348.42K | -62.60%4.34M | -58.19%1.24M | -62.24%1.49M | -73.88%539.54K | -59.26%1.07M | -30.44%11.6M | -35.99%2.96M | -34.75%3.94M | -31.29%2.07M |
Basic earnings per share | -68.33%0.57 | -63.53%7.24 | -59.37%2.06 | -63.20%2.48 | -74.50%0.9 | -60.18%1.8 | -32.41%19.85 | -37.56%5.07 | -36.48%6.74 | -33.27%3.53 |
Diluted earnings per share | -67.98%0.57 | -63.26%7.15 | -58.37%2.04 | -62.67%2.46 | -74.50%0.89 | -60.09%1.78 | -31.93%19.46 | -37.74%4.9 | -36.51%6.59 | -32.76%3.49 |
Dividend per share | 0.00%0.18 | 0.00%0.72 | 0.00%0.18 | 0.00%0.18 | 0.00%0.18 | 0.00%0.18 | 0.00%0.72 | 0.00%0.18 | 0.00%0.18 | 0.00%0.18 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |